The care of persons with recent sexual exposure to HIV

被引:65
作者
Katz, MH
Gerberding, JL
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] San Francisco Dept Publ Hlth, San Francisco, CA USA
关键词
D O I
10.7326/0003-4819-128-4-199802150-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Until recently, patients had little motivation to seek medical care soon after sexual exposure to HIV. However, evidence that antiretroviral treatment prevents HIV infection after occupational exposure has led to the recommendation that prophylaxis be considered after sexual exposure. This recommendation will result in an increased number of recently exposed patients presenting for care. Clinicians should seize this opportunity to reach persons who are at high risk for HIV seroconversion and provide them with evaluation, treatment, and counseling. A comprehensive approach to the care of persons recently exposed to HIV is proposed. Candidates for postexposure prophylaxis should be identified and given appropriate antiretroviral treatment. Physicians must perform HIV antibody testing to determine which persons are already infected with HIV and must do baseline laboratory studies. Follow-up care includes assessment of side effects from postexposure treatment and surveillance for development of primary HIV infection. Most important, clinicians must provide risk-reduction counseling to decrease the chance of future exposures. Public health messages must emphasize that postexposure treatment should be used only as a backup for failure of primary prevention methods, such as avoidance of high-risk sexual exposures or use of condoms.
引用
收藏
页码:306 / 312
页数:7
相关论文
共 77 条
[1]   ANALYSIS OF A RAPE CASE BY DIRECT SEQUENCING OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL AND GAG GENES [J].
ALBERT, J ;
WAHLBERG, J ;
LEITNER, T ;
ESCANILLA, D ;
UHLEN, M .
JOURNAL OF VIROLOGY, 1994, 68 (09) :5918-5924
[2]  
*AM MED ASS, 1996, PHYS GUID HIV PREV
[3]   HIV ANTIBODY TESTING AMONG THOSE AT RISK FOR INFECTION - THE NATIONAL AIDS BEHAVIORAL SURVEYS [J].
BERRIOS, DC ;
HEARST, N ;
COATES, TJ ;
STALL, R ;
HUDES, ES ;
TURNER, H ;
EVERSLEY, R ;
CATANIA, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (13) :1576-1580
[4]   THE SKIN AS TARGET, VECTOR, AND EFFECTOR ORGAN IN HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
BLAUVELT, A ;
KATZ, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) :S122-S126
[5]   Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate [J].
Buchbinder, SP ;
Douglas, JM ;
McKirnan, DJ ;
Judson, FN ;
Katz, MH ;
MacQueen, KM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :954-961
[6]   A case-control study of HIV seroconversion in health care workers after percutaneous exposure [J].
Cardo, DM ;
Culver, DH ;
Ciesielski, CA ;
Srivastava, PU ;
Marcus, R ;
Abiteboul, D ;
Heptonstall, J ;
Ippolito, G ;
Lot, F ;
McKibben, P ;
Bell, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) :1485-1490
[7]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[8]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[9]  
Cates W, 1995, NEW ENGL J MED, V333, P1783
[10]  
Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P574